Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 53 entries
View as:

Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00936624 Org: User:
Start: 07/31/09 End: 05/31/11 Due: 05/31/12

Assessment of Protective Effect of JOINS on Cartilage in Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT01293955 Org: User:
Start: 08/31/10 End: 09/30/13 Due: 09/30/14

Phase I Study to Investigate the Alcohol Interaction of SK3530

Phase: N/A Priority: Normal
NCT ID: NCT00489450 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530

Phase: N/A Priority: Normal
NCT ID: NCT00489606 Org: User:
Start: 04/30/07 End: 06/30/07 Due: 06/30/08

A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT00821483 Org: User:
Start: 11/30/06 End: 02/29/08 Due: 02/28/09

Clinical Trial for GNX80 in Intermittent Claudication

Phase: N/A Priority: Normal
NCT ID: NCT05400395 Org: User:
Start: 09/05/22 End: 08/31/24 Due: 08/31/25

Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03826719 Org: User:
Start: 02/17/14 End: 03/28/14 Due: 03/28/15

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT03114982 Org: User:
Start: 05/31/16 End: 11/30/16 Due: 11/30/17

Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01563432 Org: User:
Start: 01/31/12 End: 02/29/12 Due: 02/28/13

Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT01578811 Org: User:
Start: 08/31/11 End: 12/31/12 Due: 12/31/13

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05236998 Org: User:
Start: 11/03/21 End: 12/31/21 Due: 12/31/22

Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02467842 Org: User:
Start: 10/31/14 End: 05/31/15 Due: 05/31/16

Safety/Tolerability and Pharmacokinetic Study of SID142

Phase: N/A Priority: Normal
NCT ID: NCT02625714 Org: User:
Start: 06/30/15 End: 07/31/15 Due: 07/31/16

A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT05445895 Org: User:
Start: 12/16/22 End: 10/31/25 Due: 10/31/26

Phase II Trial of SK3530 in Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00351065 Org: User:
Start: 09/30/04 End: 03/31/05 Due: 03/31/06

Immunogenicity and Safety Study of NBP606 in Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT02927444 Org: User:
Start: 11/04/15 End: 10/26/17 Due: 10/26/18

Safety Study of NBP608 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03121638 Org: User:
Start: 11/30/12 End: 03/31/13 Due: 03/31/14

Study to Evaluate SID 530 Compared to Taxotere

Phase: N/A Priority: Normal
NCT ID: NCT00931008 Org: User:
Start: 10/31/09 End: 01/31/11 Due: 01/31/12

Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg

Phase: N/A Priority: Normal
NCT ID: NCT02485028 Org: User:
Start: 10/31/13 End: 11/30/13 Due: 11/30/14

Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine

Phase: N/A Priority: Normal
NCT ID: NCT00626743 Org: User:
Start: 05/31/08 End: 07/31/11 Due: 07/31/12

Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01513161 Org: User:
Start: 04/30/08 End: 10/31/09 Due: 10/31/10

Phase III Trial of Febuxostat in Korea Gout Patients

Phase: N/A Priority: Normal
NCT ID: NCT00821392 Org: User:
Start: 08/31/06 End: 09/30/07 Due: 09/30/08

Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT05930080 Org: User:
Start: 01/28/21 End: 09/30/22 Due: 09/30/23

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Phase: N/A Priority: Normal
NCT ID: NCT03120364 Org: User:
Start: 09/09/15 End: 04/28/16 Due: 04/28/17

Phase 1 Study of SK3530 to Investigate of the Effect of Food

Phase: N/A Priority: Normal
NCT ID: NCT00443625 Org: User:
Start: 12/31/06 End: 02/28/07 Due: 02/28/08